MedTrace Logo

Evaluation of Automated Laser-Assisted Tattoo Removal: a Prospective Feasibility Clinical Study

NCT07759076 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2026-08-11

No results posted yet for this study

Summary

The goal of this study is to collect preliminary clinical performance data focused on the usability aspects of the human - machine interaction, with focus on planning, navigation and application of automated laser tattoo removal. The study will enroll adult patients with monochrome dark tattoos.

In addition to the data collected on the human-machine interaction, it will also collect other outcomes like pain during treatment, overall user and patient satisfaction, and adverse events.

For the participants, treatment will follow standard procedures. In addition to this, they will be followed up after 30 days, to see if any complications occured.

Conditions

  • Only Healthy Participants Are Included in the Study
  • Persons Seeking Tattoo Removal

Interventions

DEVICE

PiRAT 1.0, tattoo removal laser

The investigational device, PiRAT, uses a standard laser, but with added automation which has the potential to perform the procedure more quickly and precisely, with less heat accumulation and less documentation required. observed, documented, and assessed in real-life circumstances.Documentation of patient / skin data

Sponsors & Collaborators

  • Raylution AG

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
84 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2026-11-30
Completion
2026-11-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07759076 on ClinicalTrials.gov